Compounds > 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole
Page last updated: 2024-11-05

3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole and Carotid Artery Narrowing

3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole has been researched along with Carotid Artery Narrowing in 2 studies

3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole: antineoplastic; activates platelet guanylate cyclase; a radiosensitizing agent and guanylate cyclase activator; structure in first source
lificiguat : A member of the class of indazoles that is 1H-indazole which is substituted by a benzyl group at position 1 and a 5-(hydroxymethyl)-2-furyl group at position 3. It is an activator of soluble guanylate cyclase and inhibits platelet aggregation.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tulis, DA2
Durante, W2
Peyton, KJ2
Chapman, GB1
Evans, AJ2
Schafer, AI2
Bohl Masters, KS1
Lipke, EA1
Schiesser, RL1
West, JL1

Other Studies

2 other studies available for 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole and Carotid Artery Narrowing

ArticleYear
YC-1, a benzyl indazole derivative, stimulates vascular cGMP and inhibits neointima formation.
    Biochemical and biophysical research communications, 2000, Dec-20, Volume: 279, Issue:2

    Topics: Angioplasty, Balloon; Animals; Carotid Arteries; Carotid Artery Injuries; Carotid Stenosis; Cyclic G

2000
YC-1-mediated vascular protection through inhibition of smooth muscle cell proliferation and platelet function.
    Biochemical and biophysical research communications, 2002, Mar-08, Volume: 291, Issue:4

    Topics: Angioplasty, Balloon; Animals; Arterial Occlusive Diseases; Blood Platelets; Carotid Stenosis; Cell

2002